MiR-200b and miR-155 as predictive biomarkers for the efficacy of chemoradiation in locally advanced head and neck squamous cell carcinoma

This publication has 39 references indexed in Scilit:

• Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation
  European Journal of Cancer, 2016
• MicroRNAs and head and neck cancer: Reviewing the first decade of research
  European Journal of Cancer, 2014
• microRNA-mediated regulation of the tumor microenvironment
  Cell Cycle, 2013
• Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death
  International Journal of Molecular Sciences, 2012
• Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity
  Carcinogenesis, 2012
• Five years' results of the German ARO 04-01 trial of concurrent 72 Gy hyperfractionated accelerated radiation therapy (HART) plus once weekly cisplatinum/5-FU versus mitomycin C/5-FU in stage IV head and neck cancer.
  Journal of Clinical Oncology, 2012
• MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
  European Journal of Cancer, 2010
• microRNAs and the immune response
  Current Opinion in Pharmacology, 2009
• Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
  Radiotherapy and Oncology, 2009
• Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets
  Cell, 2005